Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2009-03-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Healthcare Utilization and Outcomes of FinESS Treatment in the Office
NCT00986830
Clinical Evaluation of the Steroid-Eluting Sinexus Intranasal Splint When Used Following Functional Endoscopic Sinus Surgery (FESS) in Patients With Chronic Sinusitis
NCT00912405
A Clinical Evaluation of the Sinexus Intranasal Splint Following Functional Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis
NCT00840970
The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)
NCT05882903
Safety and Performance of the SinuSys Dilation System for Dilation of the Maxillary Sinus Ostium
NCT01623050
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FinESS Treatment
Subjects undergoing treatment with the FinESS Sinus Treatment System
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Entellus Medical, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Entellus Medical
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeff Grebner
Role: STUDY_DIRECTOR
Entellus Medical
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
South Denver ENT and Allergy
Denver, Colorado, United States
Gulf Coast Facial Plastics and ENR
Panama City, Florida, United States
Gensys Regional Medical Center
Grand Blanc, Michigan, United States
Paparella Group
Maple Grove, Minnesota, United States
St. Cloud Ear Nose and Throat
Saint Cloud, Minnesota, United States
Lee's Summit Ear, Nose and Throat Center
Lee's Summit, Missouri, United States
Midwest Ear, Nose and Throat
Sioux Falls, South Dakota, United States
Dickson Ear, Nose and Throat PLC
Dickson, Tennessee, United States
Austin Ear, Nose and Throat Clinic
Austin, Texas, United States
Capital Otolaryngology
Austin, Texas, United States
Texas Sinus Center
Boerne, Texas, United States
Medical Center ENT Associates of Houston
Houston, Texas, United States
Advanced Otolaryngology, PC
Richmond, Virginia, United States
Advanced Ear, Nose and Throat Specialists
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1498-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.